Myocardial Infarction, Acute (AMI)/ST Elevation Myocardial Infarction (STEMI)
Myocardial Infarction, Acute (AMI)/ST Elevation Myocardial Infarction (STEMI)
ICD 10 code: I21.0-3/I21.9/I22.0-1/I22.8-9/I24.8-9/I25.6/I25.8-9
DESCRIPTION
AMI/STEMI is caused by the complete or partial occlusion of a coronary artery and requires prompt hospitalisation and intensive care management.
The major clinical feature is severe chest pain with the following characteristics:
- Site: retrosternal or epigastric
- Quality: crushing, constricting or burning pain or discomfort
- Radiation: to the neck and/or down the inner part of the left arm
- Duration: at least 20 minutes and often not responding to sublingual nitrates
- Occurrence: at rest
May be associated with:
- Pallor
- Pulmonary oedema
- Sweating
- A decrease in blood pressure
- Arrhythmias
Note
Not all features have to be present
EMERGENCY TREATMENT
Before transfer
Cardio-pulmonary resuscitation if necessary (See: Cardiac arrest – cardiopulmonary resuscitation)
- Oxygen 40% via facemask, if saturation < 94% or if in distress
CAUTION
Do not administer oxygen to acutely ill patients who are not hypoxic (SPO2 ≥ 96%)
LoE:IIb25
AND
- Aspirin, oral, 150 mg as a single dose (chewed or dissolved) as soon as possible
LoE:Ia26
AND
- Nitrates, short acting, e.g.:
- Isosorbide dinitrate, sublingual, 5 mg, immediately as a single dose
- May be repeated at 5-minute intervals for 3 or 4 doses
LoE:IVb27
AND
- Morphine 10 mg diluted with 10 mL of water for injection or sodium chloride 0.9%, slow IV (Doctor prescribed)
- Start with 5 mg; thereafter slowly increase by 1 mg/minute up to 10mg
- Can be repeated after 4–6 hours if necessary, for pain relief
- Beware of hypotension
AND
- Thrombolytic, e.g.: (see table for time window below): (Doctor initiated), e.g.:
- Streptokinase, IV 1.5 million units diluted in 100 mL sodium chloride 0.9%, infused over 30–60 minutes. Do not use heparin if streptokinase is given
- Hypotension may occur. If it does, reduce the rate of infusion but strive to complete it in < 60 minutes
- Streptokinase is antigenic and should not be re-administered in the period of 5 days to 2 years after 1st administration
- Severe allergic reactions are uncommon but antibodies which may render it ineffective may persist for years
LoE:IIb28
LoE:IIb29
Considerations for initiating thrombolytics |
Contra-indications |
|
For acute myocardial infarction - Maximal chest pain is ≤6 hours doctor to initiate treatment - If beyond 6 hours and chest pain, consult a specialist - >6 hours and no chest pain, thrombolytic not indicated. Manage as above and refer patient. LoE:Ia30
|
Absolute:
- Streptokinase used within the last year
- Previous allergy
- CVA within the last 3 months
- History of recent major trauma
- Bleeding within the last month
- Aneurysms
- Brain or spinal surgery or head injury within the preceding month, or recent (<3 weeks) major surgery,
- Active bleeding or known bleeding disorder
- Aortic dissection
Relative (consult specialist):
- Refractory hypertension
- Warfarin therapy
- Recent retinal laser treatment
- Subclavian central venous catheter
- Pregnancy
- TIA in the preceding 6 months
-Traumatic resuscitation
|
Table 4.2: Streptokinase therapy
Note:
Refer all suspected or diagnosed cases urgently
Continuation of aftercare treatment initiated at higher level of care:
Continue therapy with appropriate lifestyle modification and adherence support
- Aspirin, oral, 150 mg daily (continued indefinitely in absence of contraindications)
LoE:Ia31
When clinically stable without signs of heart failure, hypotension, bradydysrhythmias or asthma:
- Cardio-selective beta-blocker, e.g.: (Doctor prescribed)
- Atenolol, oral, 50 mg daily
AND
- HMGCoA reductase inhibitors (statins), e.g.:
- Rosuvastatin, oral, 10 mg at night
LoE:Ia32
Patients on protease inhibitor:
- Atorvastatin, oral, 10 mg at night
LoE:Ia33
Patients on amlodipine (and not on a protease inhibitor):
- Simvastatin, oral, 10-20 mg at night
LoE:Ia34
If patient complains of muscle pain:
Reduce dose e.g.:
- If simvastatin 20 mg not tolerated, reduce to 10 mg
LoE:Ia35
OR
- Refer for further management
AND
If there is cardiac failure or LV dysfunction (Doctor initiated):
- ACE-inhibitor, e.g.:
- Enalapril, oral, target dose 10 mg 12 hourly (usually titrated from 2.5 mg 12 hourly)
LoE:Ia36
|
Angioedema is a potentially serious complication of ACE-inhibitor treatment and if it occurs it is a contraindication to continued therapy or to re-challenge. |
REFERRAL
Urgent
- All suspected or diagnosed cases
Standard Treatment Guidelines and Essential Medicines List for South Africa, Primary Healthcare, 2020-2024_Version 1.0_1 November 2024
Chapter 4: Cardiovascular Conditions_4.4 Myocardial Infarction, Acute (AMI)/ST Elevation Myocardial Infarction (STEMI)
Drugs mentioned
ICD-10 codes
- I21.0Acute transmural myocardial infarction of anterior wall
- I21.1Acute transmural myocardial infarction of inferior wall
- I21.2Acute transmural myocardial infarction of other sites
- I21.3Acute transmural myocardial infarction of unspecified site
- I21.9Acute myocardial infarction, unspecified
- I22.0Subsequent myocardial infarction of anterior wall
- I22.1Subsequent myocardial infarction of inferior wall
- I22.8Subsequent myocardial infarction of other sites
- I22.9Subsequent myocardial infarction of unspecified site
- I24.8Other forms of acute ischaemic heart disease
- I24.9Acute ischaemic heart disease, unspecified
- I25.6Silent myocardial ischaemia
- I25.8Other forms of chronic ischaemic heart disease
- I25.9Chronic ischaemic heart disease, unspecified